Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate.
In a randomized double-blind study, Swiss adults traveling to tropical countries for 12 to 28 days took a solid formulation of bismuth subsalicylate (1.05 or 2.1 g/day on a twice-daily regimen) or placebo. Efficacy was evaluated in 231 volunteers. Diarrheal incidence was reduced by 41% in persons ta...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180455/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3518624/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.29.4.625 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|